Molecular imaging in prostate cancer

Examining the role of molecular imaging in prostate cancer from staging through biochemical recurrence with Dr. Louis Mazzarelli, Director of Molecular Imaging at Lawrence and Memorial and Westerly Hospitals with Yale New Haven Health.